Outstanding Merit Award
The Outstanding Merit Award is an annual prize which recognizes the best paper published in International Immunology in the previous year. The Editorial B
Related Articles
Sepsis and Septic Shock | NEJM
Sepsis is a life-threatening, heterogeneous disorder involving a dysregulated immune response to infection. Research to identify subtypes and targeted therapies for host dysregulation is ongoing.
Cat themed fur-wrapped tri-mode keyboard now available for $240
Costs $239.00 USD, and an additional six models are planned for the future
Active Surveillance or Watchful Waiting for Intermediate-Risk Prostate Cancer
This cross-sectional study evaluates trends and factors associated with selecting active surveillance or watchful waiting among individuals with intermediate-risk prostate cancer.
Global Healthspan-Lifespan Gaps Among 183 World Health Organization Member States
This cross-sectional study quantifies the healthspan-lifespan gap around the world, assesses sex disparities, and analyzes associations with morbidity and mortality.
Atlases galore: where to next?
Nature Methods – Hundreds of researchers collaborate on maps of the human body and the subcellular realm. As they scout out their next mapping expeditions,…
The biggest digital health VC investors since 2020
While the list of venture capital firms investing in digital health has shrunk since 2021, the most active investors continue to write checks.
Alzheimer’s disease mortality among taxi and ambulance drivers: population based cross sectional study
Objective To analyze mortality attributed to Alzheimer’s disease among taxi drivers and ambulance drivers, occupations that demand frequent spatial and navigational processing, compared with other…
Exclusive: New Research Shows AI Strategically Lying
Experiments by Anthropic and Redwood Research show how Anthropic’s model, Claude, is capable of strategic deceit
Gilead plans to halt free access to an HIV drug, worrying patient advocates
Gilead Sciences will no longer provide four HIV medicines for free as part of a patient assistance program starting at the end of January.
Humanoid robots being mass produced in China
Tesla’s CEO Elon Musk said on the social media platform X earlier this year that Tesla would have robots ready for companies by 2026.